What is the appropriate dose of vitamin C to add to a hydration intravenous fluid (e.g., normal saline or lactated Ringer's) per liter?

Vitamin C Dosing in Hydration IV Fluids

For routine hydration IV fluids in stable patients, vitamin C is not typically added—standard crystalloid solutions (normal saline or lactated Ringer's) are used alone. However, when vitamin C supplementation is clinically indicated and added to IV fluids, the dose varies dramatically based on the clinical context.

Dosing Framework Based on Clinical Context

For Routine Supplementation in Parenteral Nutrition

• 100-200 mg/day IV is the standard dose when providing parenteral nutrition 1
• This represents maintenance dosing for patients unable to take oral nutrition

For Patients with Chronic Oxidative Stress

• 200-500 mg/day for patients with diabetes, heart failure, smoking history, alcoholism, severe COPD, or chronic dialysis 1
• This addresses increased metabolic demands without inflammation

For Critically Ill Patients During Acute Inflammation

• 2-3 grams per day IV during the acute phase of critical illness (Grade B recommendation) 1
• This higher "repletion dose" is necessary because:
  • Plasma vitamin C levels plummet rapidly with inflammation (undetectable when CRP >40 mg/L) 1
  • Low levels correlate with organ failure and mortality 1
  • Standard doses cannot restore normal plasma concentrations during severe inflammation

For Specific Critical Conditions

• Severe sepsis/ARDS: 200 mg/kg/day for 4 days 1
• Cardiac surgery (periprocedural): 1-2 grams/day for 5-7 days IV (Grade 1+ recommendation) 1
• Continuous renal replacement therapy (CRRT): 2-3 grams/day IV 1

Preparation and Administration

Vitamin C must be diluted with normal saline or glucose solution to minimize adverse reactions 1. The guidelines explicitly state this safety requirement for IV injection.

Research demonstrates that vitamin C solutions remain stable:

• 1.5 g per 50 mL of 0.9% saline or 2.5 g per 50 mL of D5W maintain >90% concentration for up to 96 hours at both refrigerated and ambient temperatures 2
• Light protection is not required for these dilutions 2

Critical Clinical Considerations

Do not add vitamin C to routine hydration bags for stable patients—there is no evidence supporting this practice, and it represents unnecessary medication exposure. Vitamin C supplementation should be reserved for:

1. Documented or suspected deficiency (scurvy symptoms warrant 1 g/day trial without waiting for lab confirmation) 1
2. Critical illness with inflammation where plasma levels are depleted
3. Specific high-risk conditions listed above

Important caveat: Plasma vitamin C measurement is not recommended during critical illness or severe inflammation because results are difficult to interpret—levels drop precipitously regardless of supplementation adequacy 1. Clinical decision-making should be based on the presence of inflammation (CRP levels) and clinical context rather than vitamin C levels.

Route matters profoundly: Oral vitamin C produces tightly controlled plasma concentrations (maximum ~220 μmol/L even with 3 g every 4 hours), while IV administration can achieve concentrations >13,000 μmol/L 3. This is why IV administration is essential during critical illness when enteral absorption is unpredictable and higher plasma concentrations are needed 1.

The formulation also matters—emerging evidence suggests sodium ascorbate (pH-neutral) may be superior to ascorbic acid for cardiovascular and neurological outcomes in sepsis, though this requires further validation 4.